简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
paediatric myopia
ZHAOKE OPHTH-B (06622.HK): Acquires Global Rights to NVK002 (Atropine Sulfate Eye Drops) to Fully Control Paediatric Myopia Programme Development
Tags:
ZHAOKE OPHTH-B
06622.HK
paediatric myopia
2026-07-13
Featured News
Finance
Tian Tu Capital (01973.HK): Disposal of BeBeBus Shares for Proceeds of Approximately HK$16.09 Million
Finance
China Everbright Greentech (01257.HK): Completes Issuance of Phase 2 2026 Green Medium-Term Notes (Carbon Neutrality Bonds) Worth RMB 1 Billion
Finance
New China Life Insurance (01336.HK): Positive Profit Forecast for H1 2026, Net Profit Attributable to Parent to Rise by 40%–60%
Finance
China Feihe (06186.HK): Subscribes to RMB 200 Million Financial Products of SPD Bank
Finance
GoFintech Quantum Innovation(00290.HK): Appointment of Ren Hongyu as Chief Technology Officer
Finance
Redco Healthy Living (02370.HK): Resignation of Independent Non-executive Director Zhou Mingsheng
Finance
AustAsia Group(02425.HK): Expected to Swing to Profit in Interim Period with Net Profit of RMB 90 Million to 130 Million
Finance
ICBC (01398.HK): Completes Issuance of Phase 4 2026 Tier 2 Capital Bonds Worth RMB 60 Billion
Finance
Bay Area Development (00737.HK): Appointment of Hao Yu as Non-executive Director
Finance
SSC(01033.HK): Completes Issuance of Phase 1 2026 Sci-Tech Innovation Corporate Bonds Worth RMB 1 Billion
Scan QR Code
Download App